114 related articles for article (PubMed ID: 2227573)
21. OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma.
Skov RV; Bichel P
Virchows Arch A Pathol Anat Histopathol; 1991; 419(1):59-62. PubMed ID: 2068803
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.
Chang K; Pai LH; Batra JK; Pastan I; Willingham MC
Cancer Res; 1992 Jan; 52(1):181-6. PubMed ID: 1727378
[TBL] [Abstract][Full Text] [Related]
23. Preparation of AHTG-DNR conjugates and their antitumor effect in vitro.
Zhang DH; Tang JZ; Shen GX; Shu N; Zhu HF
J Tongji Med Univ; 1990; 10(4):235-9. PubMed ID: 1711585
[TBL] [Abstract][Full Text] [Related]
24. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.
Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA
Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233
[TBL] [Abstract][Full Text] [Related]
25. A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors.
Li XG; Chen DX; Schwartz PE; Yang Z
Gynecol Oncol; 1989 Mar; 32(3):327-30. PubMed ID: 2920953
[TBL] [Abstract][Full Text] [Related]
26. Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas.
Masuho Y; Zalutsky M; Knapp RC; Bast RC
Cancer Res; 1984 Jul; 44(7):2813-9. PubMed ID: 6202400
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a conjugate of purified antibodies against human AFP-dextran-daunorubicin to human AFP-producing yolk sac tumor cell lines.
Ohkawa K; Hibi N; Tsukada Y
Cancer Immunol Immunother; 1986; 22(2):81-6. PubMed ID: 2424598
[TBL] [Abstract][Full Text] [Related]
28. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
[TBL] [Abstract][Full Text] [Related]
29. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
[TBL] [Abstract][Full Text] [Related]
30. A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro.
Xiao Z; McQuarrie SA; Suresh MR; Mercer JR; Gupta S; Miller GG
J Biotechnol; 2002 Mar; 94(2):171-84. PubMed ID: 11796170
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
Biddle WC; Haruta Y; Seon BK; Henderson ES; Sarcione EJ
Leuk Res; 1989; 13(8):699-707. PubMed ID: 2529399
[TBL] [Abstract][Full Text] [Related]
33. [Production of adriamycin covalent binding to monoclonal antibody OC-859 and its anti-tumor activities].
Zhang L
Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):346-8, 387. PubMed ID: 1804604
[TBL] [Abstract][Full Text] [Related]
34. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical determination of EGFR, OV 632 and OC 125 in primary ovarian cancer patients.
Athanassiadou P; Athanassiades P; Kyrkou K; Lazaris D; Kyragiannis G; Petrakakou E; Michalas S
Oncology; 1995; 52(2):145-9. PubMed ID: 7854775
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a monoclonal antibody, OVB1, which binds to a unique determinant in human ovarian carcinomas and myeloid cells.
Kurrasch RH; Rutherford AV; Rick ME; Gallo MG; Lovelace ET; Pastan I; Willingham MC
J Histochem Cytochem; 1989 Jan; 37(1):57-67. PubMed ID: 2461982
[TBL] [Abstract][Full Text] [Related]
37. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
38. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of different antigenic markers on moieties that bear CA 125 determinants.
Yu YH; Schlossman DM; Harrison CL; Rhinehardt-Clark A; Soper JT; Klug TL; Zurawski VR; Bast RC
Cancer Res; 1991 Jan; 51(2):468-75. PubMed ID: 1702359
[TBL] [Abstract][Full Text] [Related]
40. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.
Yokota S; Hara H; Luo Y; Seon BK
Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
